載入...
The MEK Inhibitors Trametinib and Cobimetinib Induce a Type I Interferon Response in Human Keratinocytes
Mitogen-activated protein kinase kinases (MEK) 1 and 2 have crucial roles in tumorigenesis, cell proliferation, and protection from apoptosis, and their inhibition is therefore an attractive therapeutic strategy in cancer. Orally available and highly selective MEK inhibitors have been developed and...
Na minha lista:
| 發表在: | Int J Mol Sci |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
MDPI
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5666906/ https://ncbi.nlm.nih.gov/pubmed/29064427 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms18102227 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|